Vireo Growth (VREOF) Total Current Liabilities (2020 - 2026)
Vireo Growth's (VREOF) quarterly Total Current Liabilities came in at $215.8 million in Q1 2026, up 56.77% year-on-year from $137.7 million in Q1 2025, and up 12.57% quarter-over-quarter from $191.7 million in Q4 2025.
Vireo Growth (VREOF) Total Current Liabilities (2020 - 2026) Analysis & Trends
Vireo Growth has disclosed Total Current Liabilities across 7 years of filings, most recently posting $215.8 million for Q1 2026.
- Total Current Liabilities for Q1 2026 came in at $215.8 million, up 56.77% year-over-year; the trailing twelve-month figure through Mar 2026 was $215.8 million (up 56.77% YoY), and the FY2025 annual result was $191.7 million, up 41.51% from the prior year.
- Total Current Liabilities came in at $215.8 million for Q1 2026 at Vireo Growth, up from $191.7 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $243.5 million in Q2 2025 to a low of $18.5 million in Q2 2022.
- The 5-year median for Total Current Liabilities is $157.0 million (2023), against an average of $138.3 million.
- Across the five-year window, Total Current Liabilities surged 747.46% in 2023 and fell 25.28% in 2025, its largest moves.
- Vireo Growth's Total Current Liabilities stood at $29.7 million in 2022, then surged by 504.09% to $179.5 million in 2023, then slipped by 24.52% to $135.5 million in 2024, then jumped by 41.51% to $191.7 million in 2025, then climbed by 12.57% to $215.8 million in 2026.
- The last three Total Current Liabilities figures came in at $215.8 million (Q1 2026), $191.7 million (Q4 2025), and $234.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 13.53 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 2.05 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 831.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 1.66 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 599.50 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 618.78 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 333.17 Mn |
| 10 | Vireo Growth | - | - | 59.30 Mn | 215.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 215.80 Mn |
| Dec 31, 2025 | 191.70 Mn |
| Sep 30, 2025 | 234.91 Mn |
| Jun 30, 2025 | 243.52 Mn |
| Mar 31, 2025 | 137.66 Mn |
| Dec 31, 2024 | 135.47 Mn |
| Sep 30, 2024 | 128.77 Mn |
| Jun 30, 2024 | 186.77 Mn |
| Mar 31, 2024 | 184.24 Mn |
| Dec 31, 2023 | 179.47 Mn |
| Sep 30, 2023 | 165.42 Mn |
| Jun 30, 2023 | 157.00 Mn |
| Mar 31, 2023 | 95.17 Mn |
| Dec 31, 2022 | 29.71 Mn |
| Sep 30, 2022 | 26.35 Mn |
| Jun 30, 2022 | 18.53 Mn |
| Mar 31, 2022 | 20.52 Mn |
| Dec 31, 2021 | 16.41 Mn |
| Sep 30, 2021 | 15.23 Mn |
| Jun 30, 2021 | 16.11 Mn |